Chen Tu
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Low-dose decitabine combined with camrelizumab for refractory/relapsed mycosis fungoides/Sézary syndrome: a retrospective exploratory study.
Journal: Frontiers in oncology
Published: April 09, 2026
Comprehensive post-marketing safety analysis of tildrakizumab: insights from the FDA adverse event reporting system.
Journal: Expert opinion on drug safety
Published: June 13, 2025
Safety assessment of apremilast: real-world adverse event analysis from the FAERS database.
Journal: Archives of dermatological research
Published: February 17, 2025
Real-world safety of deucravacitinib: insights from the Food and Drug Administration Adverse Event Reporting System.
Journal: International journal of clinical pharmacy
Published: October 18, 2024
Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database.
Journal: Frontiers in pharmacology
Published: September 17, 2024
Assessing the real-world safety of tralokinumab for atopic dermatitis: insights from a comprehensive analysis of FAERS data.
Journal: Frontiers in pharmacology
Published: July 02, 2024
Oral Microbiota Variations in Psoriasis Patients Without Comorbidity.
Journal: Clinical, cosmetic and investigational dermatology
Published: April 10, 2024
FOXN3 Regulates Autophagic Activity to Suppress Drug Resistance in Melanoma Cells.
Journal: Clinical, cosmetic and investigational dermatology
Published: March 14, 2024
Combining superpulse dynamic CO2 laser and supramolecular salicylic acid in the treatment of dense comedones with higher clearance in a shorter time: A prospective, randomized, split-face clinical trial.
Journal: Lasers in surgery and medicine
Published: June 14, 2023
Last Updated: 09/26/2026